InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by LaBarre Michael J., Chief Technology Officer. Officer active across 1 companies, notably Halozyme Therapeutics, INC.. Aggregated, 12 reports have been published. The latest transaction was disclosed on 15 February 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
03,386 shares0
Common Stock
SEC:0001179110-22-001394:0·
08,133 shares0
Common Stock
SEC:0001179110-22-001201:0·
€91,4298,050 shares@ €11.35770.0011% mcap11.0% of flow
Common Stock
SEC:0001179110-21-009380·
€91,4298,050 shares@ €11.35770.0011% mcap5.5% of flow
Common Stock
SEC:0001179110-21-009380:0·
€333,31529,450 shares@ €11.3180.0042% mcap39.9% of flow
Common Stock
SEC:0001179110-21-009057·
€333,31529,450 shares@ €11.3180.0042% mcap20.0% of flow
Common Stock
SEC:0001179110-21-009057:0·
€81,43314,685 shares@ €5.54530.0010% mcap9.8% of flow
Common Stock
SEC:0001179110-21-007506·
€81,43314,685 shares@ €5.54530.0010% mcap4.9% of flow
Common Stock
SEC:0001179110-21-007506:0·
€222,90940,315 shares@ €5.52920.0028% mcap26.7% of flow
Common Stock
SEC:0001179110-21-007391·
€222,90940,315 shares@ €5.52920.0028% mcap13.3% of flow
Common Stock
SEC:0001179110-21-007391:0·
€105,87711,311 shares@ €9.36050.0013% mcap12.7% of flow
Common Stock
SEC:0001179110-21-004815·
€105,87711,311 shares@ €9.36050.0013% mcap6.3% of flow
Common Stock
SEC:0001179110-21-004815:0·
12 of 12 declarations
About LaBarre Michael J.
Michael J. LaBarre serves as Senior Vice President and Chief Technical Officer at Halozyme Therapeutics, Inc. In this role, he oversees the company's technological development and innovation initiatives. Michael plays a key role in improving products and processes, thereby contributing to Halozyme's growth. His expertise in biotechnology and product development enables him to effectively lead the company toward new opportunities.
